/
Respiratory
Chronic Cough
11
Pipeline Programs↗
10
Active Trials↗
20
Companies Involved↗
Chronic Cough is an emerging landscape with 11 programs across 20 companies. The most active players are Jiangsu Hansoh Pharmaceutical Co., Ltd., Hubei Bio-Pharmaceutical Industrial Technological Institute Inc., Nocion Therapeutics. 1 program is in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical5
Phase 1
No programs
Phase 25
Phase 31
Approved
No programs
Analysis
Trial Status
63
clinical trials
Completed42 · 67%
Recruiting8 · 13%
Unknown status6 · 10%
Terminated4 · 6%
Not yet recruiting2 · 3%
Withdrawn1 · 2%
Clinical Trials
Trial Activity
63 trials
Effect of Gefapixant on Cough-related Brain Activity in Patients With Chronic Cough
Recruiting·—·Phase 1·NCT05813223·31 enrolled
A Phase 2 Study of HW091077 in Participants With Refractory Chronic Cough Or Unexplained Chronic Cough (RCC/UCC).
Not yet recruiting·HHubei Bio-Pharmaceutical Industrial Technological Institute Inc.·Phase 2·NCT07483489·180 enrolled
Page 1 of 5
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)